Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

However, Devin Koontz, with the FDA, clarified that the agency did not ban Filipino products but expressed concern over high levels of BHA and potassium iodate in some products.

(1) The total number of outstanding shares of the Company on 24 January 2025 mentioned in the relevant transparency notifications amounts to 52,416,601, each share giving right to one (1) vote (being ...

Civil servants are facing increasing pressure to leave their jobs as a deadline approaches to take a deal offered by the ...

A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

The health care advocacy group said removing health information to comply with Trump's executive orders worsens medical care ...

Strattera is prescribed to treat ADHD. Learn more about how long the drug takes to kick in and how long it lasts.

The removal of the content comes after the US Office of Personnel Management directed federal agencies earlier this week to ...

The Trump administration was sued in separate civil complaints challenging a request for information about FBI employees who ...